Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global generic drug market expected to reach USD 380.60 billion by 2021, growing at a CAGR of 10.8 % between 2016 and 2021.

06-Oct-2016 | Number of pages: 110 | Report Code: ZMR-212 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the generic drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the generic drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the generic drug market on a global level.

This report offers comprehensive coverage on global generic drug market along with, market trends, drivers, and restraints of the generic drug market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the generic drug market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.

The study provides a decisive view on the generic drug market by segmenting the market based on brand, therapeutic and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The brand based market covered under this study includes pure generic drugs and branded generic drugs. The therapeutic application based market covered under this study includes central nervous system (CNS), cardiovascular, dermatology, oncology, respiratory and others. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Key operating players for generic drugs market are Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Abbott Healthcare Pvt Ltd, Actavis Pharmaceuticals and Sun Pharmaceuticals.

This report segments the generic drugs market as follows:

Generic Drugs Market: Brand Segment Analysis

  • Pure generic drugs
  • Branded generic drugs

Generic Drugs Market: Therapeutic Application Segment Analysis

  • Central nervous system (CNS)
  • Cardiovascular
  • Dermatology
  • Oncology
  • Respiratory
  • Others.

Generic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Medical Foam Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1129 | Report Format:

Global Medical Foam Market: Overview Medical graded foam has specific antimicrobial substances present in it in order to reduce the risks of the spread of bacteria, germs, and diseases in the hospitals or other medical sectors by its property of resisting against the contaminants. The medical fo...Read More

Chromatography Reagents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1112 | Report Format:

Global Chromatography Reagents Market: Overview Chromatography is a parting method utilized to separate solutes and components in the moving fluid stream via chromatographic reagents. Chromatography has several applications in chemical and biological fields. Chromatography method and its reagent...Read More

Antinuclear Antibody Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1085 | Report Format:

Global Antinuclear Antibody Test Market: Overview The antinuclear antibodies are autoantibodies that attach to the specific contents of the nucleus present in the cell. They are also known as antinuclear factor or ANF. The autoantibodies are produced in the human body against the foreign particl...Read More

Myocardial Infarction Treatment Market by Product type (Antiplatelet agents, Glycoprotein IIb/IIIa inhibitors, Antithrombotic agents, Beta-adrenergic blockers, Vasodilators, Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin-Receptor blockers, Analgesics, Thrombolytics); Distribution channel (Hospitals, Hospital Pharmacies, Drug Stores and Online Drug Stores); and Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Feb-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-1084 | Report Format:

The report covers forecast and analysis for the myocardial infarction treatment market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the myocardial infarct...Read More

In Vitro Diagnostics (IVD) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1065 | Report Format:

Global In Vitro Diagnostics (IVD) Market: Overview In-vitro diagnostics tests are the tests performed outside the body of a patient. It uses reagents, devices, calibrators, analytical instruments, and systems for examination, detection of diseases, and health condition. Global In Vitro Diagnos...Read More

Choose License Type:
Latest Published Reports

View All Published Reports